-
1
-
-
0037187083
-
Nucleation control in solution mediated polymorphic phase transformations: The case of 2,6-dihydroxybenzoic acid
-
DOI 10.1021/jp013044i
-
Davey, R. J.; Blagden, N.; Righini, S.; Alison, H.; Ferrari, E. S. Nucleation Control in Solution Mediated Polymorphic Phase Transformations: The Case of 2,6-Dihydroxybenzoic Acid J. Phys. Chem. B 2002, 106 (8) 1954-1959 (Pubitemid 35276018)
-
(2002)
Journal of Physical Chemistry B
, vol.106
, Issue.8
, pp. 1954-1959
-
-
Davey, R.J.1
Blagden, N.2
Righini, S.3
Alison, H.4
Ferrari, E.S.5
-
3
-
-
78650301389
-
Solubility of α-form and β-form of l-glutamic acid in different aqueous solvent mixtures
-
Mo, Y.; Dang, L.; Wei, H. Solubility of α-form and β-form of l-glutamic acid in different aqueous solvent mixtures Fluid Phase Equilib. 2011, 300 (1-2) 105-109
-
(2011)
Fluid Phase Equilib.
, vol.300
, Issue.1-2
, pp. 105-109
-
-
Mo, Y.1
Dang, L.2
Wei, H.3
-
4
-
-
53149128359
-
Characterization of a Polymorphic System Exhibiting Substantial Variation of Solubility in a Fluorinated Solvent
-
Côte, M.; Hughes, C. E.; Austin, T. K.; Rogueda, P. G. A.; Pan, Z.; Harris, K. D. M.; Griffiths, P. C. Characterization of a Polymorphic System Exhibiting Substantial Variation of Solubility in a Fluorinated Solvent J. Phys. Chem. C 2008, 112 (37) 14570-14578
-
(2008)
J. Phys. Chem. C
, vol.112
, Issue.37
, pp. 14570-14578
-
-
Côte, M.1
Hughes, C.E.2
Austin, T.K.3
Rogueda, P.G.A.4
Pan, Z.5
Harris, K.D.M.6
Griffiths, P.C.7
-
5
-
-
0033029565
-
Solubility behavior of polymorphs I and II of mefenamic acid in solvent mixtures
-
DOI 10.1016/S0378-5173(98)00375-5, PII S0378517398003755
-
Romero, S.; Escalera, B.; Bustamante, P. Solubility behavior of polymorphs I and II of mefenamic acid in solvent mixtures Int. J. Pharm. 1999, 178 (2) 193-202 (Pubitemid 29078573)
-
(1999)
International Journal of Pharmaceutics
, vol.178
, Issue.2
, pp. 193-202
-
-
Romero, S.1
Escalera, B.2
Bustamante, P.3
-
6
-
-
33846108688
-
Clopidogrel bisulfate: In ST-segment elevation myocardial infarction
-
DOI 10.2165/00129784-200606060-00008
-
Dickie, J. S.; Scott, L. J. Clopidogrel bisulfate in ST-segment elevation myocardial infarction Am. J. Cardiovasc. Drugs 2006, 6, 407-414 (Pubitemid 46072397)
-
(2006)
American Journal of Cardiovascular Drugs
, vol.6
, Issue.6
, pp. 407-414
-
-
Dickie, J.S.1
Scott, L.J.2
-
7
-
-
77956855450
-
Monoclinic form i of clopidogrel hydrogen sulfate from powder diffraction data
-
Chernyshev, V. V.; Pirogov, S. V.; Shishkina, I. N.; Velikodny, Y. A. Monoclinic form I of clopidogrel hydrogen sulfate from powder diffraction data Acta Crystallogr., Sect. E 2010, 66 (8) o2101-o2102
-
(2010)
Acta Crystallogr., Sect. e
, vol.66
, Issue.8
-
-
Chernyshev, V.V.1
Pirogov, S.V.2
Shishkina, I.N.3
Velikodny, Y.A.4
-
8
-
-
77956496721
-
Solubility of Clopidogrel Hydrogen Sulfate (Form II) in Different Solvents
-
Song, L.; Li, M.; Gong, J. Solubility of Clopidogrel Hydrogen Sulfate (Form II) in Different Solvents J. Chem. Eng. Data 2010, 55 (9) 4016-4018
-
(2010)
J. Chem. Eng. Data
, vol.55
, Issue.9
, pp. 4016-4018
-
-
Song, L.1
Li, M.2
Gong, J.3
-
9
-
-
68149109385
-
-
U.S. Patent 6,429,210 B1.
-
Bousquet, A.; Castro, B.; Saint-Germain, J. Polymorphic clopidogrel hydrogenesulphate form. U.S. Patent 6,429,210 B1, 2002.
-
(2002)
Polymorphic Clopidogrel Hydrogenesulphate Form
-
-
Bousquet, A.1
Castro, B.2
Saint-Germain, J.3
-
10
-
-
1642519923
-
Solubility of Niacin in 3-Picoline + Water from (287.65 to 359.15) K
-
Wang, L.-C.; Wang, F.-A. Solubility of Niacin in 3-Picoline + Water from (287.65 to 359.15) K J. Chem. Eng. Data 2003, 49 (1) 155-156
-
(2003)
J. Chem. Eng. Data
, vol.49
, Issue.1
, pp. 155-156
-
-
Wang, L.-C.1
Wang, F.-A.2
-
12
-
-
38749137036
-
Solubility of molecular crystals: Polymorphism in the light of solubility theory
-
DOI 10.1016/j.ijpharm.2007.09.021, PII S0378517307007776
-
Bennema, P.; van Eupen, J.; van der Wolf, B. M. A.; Los, J. H.; Meekes, H. Solubility of molecular crystals: Polymorphism in the light of solubility theory Int. J. Pharm. 2008, 351 (1-2) 74-91 (Pubitemid 351186848)
-
(2008)
International Journal of Pharmaceutics
, vol.351
, Issue.1-2
, pp. 74-91
-
-
Bennema, P.1
Van Eupen, J.2
Van Der Wolf, B.M.A.3
Los, J.H.4
Meekes, H.5
-
13
-
-
0037473468
-
Characterization of piroxicam crystal modifications
-
DOI 10.1016/S0378-5173(03)00057-7
-
Vrecer, F.; Vrbinc, M.; Meden, A. Characterization of piroxicam crystal modifications Int. J. Pharm. 2003, 256 (1-2) 3-15 (Pubitemid 36412135)
-
(2003)
International Journal of Pharmaceutics
, vol.256
, Issue.1-2
, pp. 3-15
-
-
Vrecer, F.1
Vrbinc, M.2
Meden, A.3
-
14
-
-
0036785606
-
Solid phases of tenoxicam
-
Cantera, R. G.; Leza, M. G.; Bachiller, C. M. Solid phases of tenoxicam J. Pharm. Sci. 2002, 91 (10) 2240-2251
-
(2002)
J. Pharm. Sci.
, vol.91
, Issue.10
, pp. 2240-2251
-
-
Cantera, R.G.1
Leza, M.G.2
Bachiller, C.M.3
-
15
-
-
78651384366
-
Solubility of Forms i and II of Clopidogrel Hydrogen Sulfate in Methanol and 2-Propanol Mixture
-
Choi, W.-S.; Kim, K.-J. Solubility of Forms I and II of Clopidogrel Hydrogen Sulfate in Methanol and 2-Propanol Mixture J. Chem. Eng. Data 2010, 56 (1) 43-47
-
(2010)
J. Chem. Eng. Data
, vol.56
, Issue.1
, pp. 43-47
-
-
Choi, W.-S.1
Kim, K.-J.2
|